SGHT Sight Sciences, Inc.
Healthcare$4.99-0.80%ClosedMarket Cap: $271.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.03
P/S
3.44
EV/EBITDA
-7.07
DCF Value
$1.19
FCF Yield
-9.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.2%
Operating Margin
-44.8%
Net Margin
-46.8%
ROE
-59.1%
ROA
-34.0%
ROIC
-37.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $19.7M | 86.2% | $-12.4M | $-13.0M | $— | — |
| Q4 null | $20.4M | 87.3% | $-3.7M | $-4.2M | $— | — |
| FY null | $77.4M | 86.2% | $-37.1M | $-38.4M | $— | — |
| Q3 null | $19.9M | 86.4% | $-7.9M | $-8.2M | $— | — |
| Q2 null | $19.6M | 84.8% | $-11.7M | $-11.9M | $— | — |
| Q1 null | $17.5M | 86.2% | $-13.9M | $-14.2M | $— | — |
| Q4 null | $19.1M | 86.8% | $-11.9M | $-11.8M | $— | — |
| FY null | $79.9M | 85.5% | $-50.5M | $-51.5M | $— | — |
| Q3 null | $20.2M | 83.9% | $-11.2M | $-11.1M | $— | — |
| Q2 null | $21.4M | 85.8% | $-12.7M | $-12.3M | $— | — |
| Q1 null | $19.3M | 85.5% | $-14.7M | $-16.3M | $— | — |
| Q4 2023 | $18.8M | 85.2% | $-11.1M | $-10.7M | $-0.22 | — |